The emerging therapy of the medication represents a significant breakthrough in the care of type 2 diabetes. Distinct from existing medications, tirzepatide targets dual pathways – the GLP-1 hormone and GIP – https://tirzepatidepeptide363538.blogoxo.com/42409065/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment